AU2001251351A1 - Genes expressed in foam cell differentiation - Google Patents
Genes expressed in foam cell differentiationInfo
- Publication number
- AU2001251351A1 AU2001251351A1 AU2001251351A AU5135101A AU2001251351A1 AU 2001251351 A1 AU2001251351 A1 AU 2001251351A1 AU 2001251351 A AU2001251351 A AU 2001251351A AU 5135101 A AU5135101 A AU 5135101A AU 2001251351 A1 AU2001251351 A1 AU 2001251351A1
- Authority
- AU
- Australia
- Prior art keywords
- cell differentiation
- genes expressed
- foam cell
- foam
- genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000024245 cell differentiation Effects 0.000 title 1
- 210000000497 foam cell Anatomy 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19510600P | 2000-04-05 | 2000-04-05 | |
| US60/195,106 | 2000-04-05 | ||
| PCT/US2001/011128 WO2001077389A2 (fr) | 2000-04-05 | 2001-04-04 | Genes exprimes lors de la differenciation de cellules spumeuses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001251351A1 true AU2001251351A1 (en) | 2001-10-23 |
Family
ID=22720073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001251351A Abandoned AU2001251351A1 (en) | 2000-04-05 | 2001-04-04 | Genes expressed in foam cell differentiation |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030165924A1 (fr) |
| EP (1) | EP1358347A2 (fr) |
| JP (1) | JP2004532602A (fr) |
| AU (1) | AU2001251351A1 (fr) |
| CA (1) | CA2403946A1 (fr) |
| WO (1) | WO2001077389A2 (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0018307D0 (en) | 2000-07-26 | 2000-09-13 | Aventis Pharm Prod Inc | Polypeptides |
| DE60143354D1 (de) * | 2000-03-31 | 2010-12-09 | Aventis Pharma Inc | Nuklearfaktor kb induzierender faktor |
| US20020150922A1 (en) * | 2000-11-20 | 2002-10-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20020142379A1 (en) * | 2001-03-27 | 2002-10-03 | Wei Shao | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| US7700293B2 (en) | 2001-08-02 | 2010-04-20 | The Regents Of The University Of Michigan | Expression profile of prostate cancer |
| US7229774B2 (en) | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
| US7332290B2 (en) | 2001-08-02 | 2008-02-19 | The Regents Of The University Of Michigan | Dectection of AMACR cancer markers in urine |
| GB0207533D0 (en) | 2002-04-02 | 2002-05-08 | Oxford Glycosciences Uk Ltd | Protein |
| EP1362914A3 (fr) * | 2002-05-15 | 2004-05-06 | Schering AG | Inhibiteur d'histone désacétylase et son utilisation |
| GB0216727D0 (en) | 2002-07-17 | 2002-08-28 | Univ Cambridge Tech | Genes |
| EP2444409A2 (fr) * | 2002-09-16 | 2012-04-25 | Genentech, Inc. | Compositions et procédés pour le traitement de maladies liées au système immunitaire |
| US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
| SE0302122D0 (sv) * | 2003-07-22 | 2003-07-22 | Astrazeneca Ab | Genetic marker |
| US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
| EP1522857A1 (fr) | 2003-10-09 | 2005-04-13 | Universiteit Maastricht | Méthode pour identifier des individus qui risquent de développer une défaillance cardiaque par la détection du taux de galectine-3 ou thrombospondine-2 |
| ES2397661T3 (es) | 2006-08-04 | 2013-03-08 | Isis Pharmaceuticals, Inc. | Composiciones y sus usos dirigidos a la diacilglicerol aciltransferasa 1 |
| US8139065B2 (en) * | 2007-07-26 | 2012-03-20 | Chii Ying Co., Ltd. | Machine-implemented method and electronic device for presenting a dual-axis graph |
| US20090027395A1 (en) * | 2007-07-26 | 2009-01-29 | Chii Ying Co., Ltd. | Machine-implemented method and electronic device for presenting a normalized graph for a plurality of data sets |
| TW200949757A (en) * | 2008-05-28 | 2009-12-01 | Chii Ying Co Ltd | Method and system for generating normalized graph for data sets |
| US8947434B2 (en) * | 2008-07-24 | 2015-02-03 | Chii Ying Co. Ltd. | Process for determining, scaling, providing, comparative information in accurate, useful, easily recognized, and understandable manner |
| SG178531A1 (en) | 2009-08-25 | 2012-03-29 | Bg Medicine Inc | Galectin-3 and cardiac resynchronization therapy |
| US8407221B2 (en) * | 2010-07-09 | 2013-03-26 | International Business Machines Corporation | Generalized notion of similarities between uncertain time series |
| CN109477106B (zh) | 2015-07-10 | 2022-10-04 | Ionis制药公司 | 二酰基甘油酰基转移酶2(dgat2)的调节剂 |
| WO2021025625A1 (fr) * | 2019-08-08 | 2021-02-11 | Agency For Science, Technology And Research | Composés pour le traitement de l'hépatite b |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968770A (en) * | 1995-02-10 | 1999-10-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| CN1289372A (zh) * | 1998-01-26 | 2001-03-28 | 舍林公开股份有限公司 | 筛选化合物的基因表达方法 |
-
2001
- 2001-04-04 WO PCT/US2001/011128 patent/WO2001077389A2/fr not_active Application Discontinuation
- 2001-04-04 US US10/240,965 patent/US20030165924A1/en not_active Abandoned
- 2001-04-04 CA CA002403946A patent/CA2403946A1/fr not_active Abandoned
- 2001-04-04 EP EP01924723A patent/EP1358347A2/fr not_active Withdrawn
- 2001-04-04 AU AU2001251351A patent/AU2001251351A1/en not_active Abandoned
- 2001-04-04 JP JP2001575243A patent/JP2004532602A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2403946A1 (fr) | 2001-10-18 |
| JP2004532602A (ja) | 2004-10-28 |
| EP1358347A2 (fr) | 2003-11-05 |
| WO2001077389A3 (fr) | 2003-04-24 |
| US20030165924A1 (en) | 2003-09-04 |
| WO2001077389A2 (fr) | 2001-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001251351A1 (en) | Genes expressed in foam cell differentiation | |
| AU2126502A (en) | Gene expression profiles in granulocytic cells | |
| AU3316600A (en) | Gene expression in bladder tumors | |
| AU5268001A (en) | Fuel cell | |
| AU2002225681A1 (en) | Yeast-dentritic cell vaccines and uses thereof | |
| AU2001240126A1 (en) | Lithium cell | |
| AU2002321903A1 (en) | Molecular interactions in cells | |
| AU2001250036A1 (en) | Microdroplet cell culture technique | |
| AU2002239336A1 (en) | Molecular interactions in hematopoietic cells | |
| AU2001292317A1 (en) | Fuel cell | |
| AU2001235452A1 (en) | Cell culture media | |
| AU6001401A (en) | Flat lithium cell | |
| AUPQ520600A0 (en) | Improvements in electrolysis cells | |
| SG86407A1 (en) | Regenerative tie-high tie-low cell | |
| AU2001283287A1 (en) | Method for distributing electrolyte in batteries | |
| AU2001267724A1 (en) | Electrochemical cell | |
| AU4474401A (en) | Fuel for use in fuel cell | |
| AU4688701A (en) | Fuel for use in fuel cell system | |
| AU2002232032A1 (en) | Electrochemical cells and their packaging | |
| AU2001270478A1 (en) | Gene expression in biological conditions | |
| AU2001269081A1 (en) | Electrochemical cells | |
| AU2001286809A1 (en) | Genes expressed in the cell cycle | |
| AU4688401A (en) | Fuel for use in fuel cell system | |
| AU2002215354A1 (en) | Molecular interactions in hematopoietic cells | |
| AU2001244743A1 (en) | Fuel for use in fuel cell system |